HemaSphere (Apr 2022)
B04: COMBINATION OF SUBCUTANEOUS TECLISTAMAB WITH DARATUMUMAB IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM): RESULTS FROM A PHASE 1B MULTICOHORT STUDY
- P Rodriguez-Otero,
- B Dholaria,
- E Askari,
- D Reece,
- N van de Donk,
- A Chari,
- H Goldschmidt,
- A Krishnan,
- T Martin,
- M Mateos,
- D Morillo,
- C Rodriguez,
- L Rosinol,
- J San-Miguel,
- A Balari,
- R Wäsch,
- K Weisel,
- R Verona,
- S Lin,
- T Prior,
- M Wade,
- B Weiss,
- J Goldberg,
- A Oriol,
- P Hari
Affiliations
- P Rodriguez-Otero
- 1 Clínica Universidad de Navarra, Navarra (ES)
- B Dholaria
- 2 Vanderbilt University Medical Center, Nashville (USA)
- E Askari
- 3 Hospital Universitario Fundación Jiménez Díaz, Madrid (ES)
- D Reece
- 4 Princess Margaret Cancer Centre, Toronto (CA)
- N van de Donk
- 5 Amsterdam University Medical Center, Vrije Universiteit Amsterdam, Amsterdam (NL)
- A Chari
- 6 Mount Sinai School of Medicine, New York (USA)
- H Goldschmidt
- 7 University Hospital Heidelberg, Internal Medicine and National Center for Tumor Diseases (NCT), Heidelberg (DE)
- A Krishnan
- 8 City of Hope Comprehensive Cancer Center, Duarte (USA)
- T Martin
- 9 University of California, San Francisco, San Francisco (USA)
- M Mateos
- 10 University Hospital of Salamanca/IBSAL/CIC/CIBERONC, Salamanca (ES)
- D Morillo
- 3 Hospital Universitario Fundación Jiménez Díaz, Madrid (ES)
- C Rodriguez
- 11 Wake Forest University School of Medicine, Winston-Salem (USA)
- L Rosinol
- 12 Institute of Hematology and Oncology, IDIBAPS Hospital Clínic University of Barcelona, Barcelona (ES)
- J San-Miguel
- 1 Clínica Universidad de Navarra, Navarra (ES)
- A Balari
- 13 Institut Català d’Oncologia – Hospitalet, IDIBELL, University of Barcelona, Barcelona (ES)
- R Wäsch
- 14 Freiburg University Medical Center, Freiburg (DE)
- K Weisel
- 15 University Medical Center Hamburg-Eppendorf, Hamburg (DE)
- R Verona
- 16 Janssen Research & Development, Spring House (USA)
- S Lin
- 16 Janssen Research & Development, Spring House (USA)
- T Prior
- 16 Janssen Research & Development, Spring House (USA)
- M Wade
- 16 Janssen Research & Development, Spring House (USA)
- B Weiss
- 16 Janssen Research & Development, Spring House (USA)
- J Goldberg
- 17 Janssen Research & Development, Raritan (USA)
- A Oriol
- 18 Institut Català d’Oncologia and Institut Josep Carreras, Hospital Germans Trias i Pujol, Barcelona (ES)
- P Hari
- 19 Medical College of Wisconsin, Milwaukee (USA).
- DOI
- https://doi.org/10.1097/01.HS9.0000829556.56345.01
- Journal volume & issue
-
Vol. 6
pp. 7 – 8
Abstract
No abstracts available.